4//SEC Filing
Morris Carl Ashley 4
Accession 0000899243-23-003085
CIK 0001707502other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 9:18 PM ET
Size
9.4 KB
Accession
0000899243-23-003085
Insider Transaction Report
Form 4
Morris Carl Ashley
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-01-27$7.49/sh−441$3,303→ 19,760 total - Exercise/Conversion
Common Stock
2023-01-27+1,233→ 20,201 total - Exercise/Conversion
Restricted Stock Units
2023-01-27−1,233→ 3,700 total→ Common Stock (1,233 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
- [F3]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
- [F4]On January 27, 2022 (the "Grant Date"), the reporting person was granted 4,933 restricted stock units, vesting in four equal installments on the anniversary of the grant date.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727571
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 9:18 PM ET
- Size
- 9.4 KB